Fig. 1From: Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocolSchematic flowchart providing an overview of the study design; wt, wild-type; mCRC, metastatic colorectal cancer; 1 L, first-line treatment; 2 L, second-line treatment; PD, progression of diseaseBack to article page